These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22508971)

  • 1. Journal of the Royal Society of Medicine. Foreword from the medical technology industries.
    J R Soc Med; 2012 Apr; 105 Suppl 1(Suppl 1):S3. PubMed ID: 22508971
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive change: connecting the virtual and the real.
    Wiederhold BK; Riva G
    Stud Health Technol Inform; 2014; 199():3-9. PubMed ID: 24875680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health plan 2009. Technology's good and ill effects.
    Newhouse J
    Manag Care; 2004 Jan; 13(1):25. PubMed ID: 14763273
    [No Abstract]   [Full Text] [Related]  

  • 4. A look into the future: physicians' predictions about medicine.
    Peota C
    Minn Med; 2013 Dec; 96(12):16-25. PubMed ID: 24597190
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomedical entrepreneurship should be the fourth mission of all healthcare organizations.
    Meyers AD
    MedGenMed; 2007 Feb; 9(1):33. PubMed ID: 17435639
    [No Abstract]   [Full Text] [Related]  

  • 6. Armed with innovation. Israel has become a prolific developer of new medical technologies and the nation's dominant defense industry is often the incubator.
    Becker C
    Mod Healthc; 2005 Apr; 35(14):26-9. PubMed ID: 15825959
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology.
    Fraser AG; Daubert JC; Van de Werf F; Estes NA; Smith SC; Krucoff MW; Vardas PE; Komajda M;
    Eur Heart J; 2011 Jul; 32(13):1673-86. PubMed ID: 21572115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are hospitals next in line? Government investigators probing relationships between physicians, devicemakers may soon train sights on hospitals.
    Taylor M
    Mod Healthc; 2006 Aug; 36(32):24-6. PubMed ID: 16958280
    [No Abstract]   [Full Text] [Related]  

  • 9. The future of telemedicine & its Faustian reliance on regulatory trade barriers for protection.
    McLean TR
    Health Matrix Clevel; 2006; 16(2):443-509. PubMed ID: 16948249
    [No Abstract]   [Full Text] [Related]  

  • 10. Hegemony in the marketplace of biomedical innovation: consumer demand and stem cell science.
    Salter B; Zhou Y; Datta S
    Soc Sci Med; 2015 Apr; 131():156-63. PubMed ID: 25771483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare in the new millennium: the long boom meets the civil society.
    Morrison I; Schwartz P; Yankelovich D
    Healthc Forum J; 1998; 41(3):18-22, 70, 72-7. PubMed ID: 10180187
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of the European Union enlargement on health professionals and health care systems.
    Avgerinos ED; Koupidis SA; Filippou DK
    Health Policy; 2004 Sep; 69(3):403-8. PubMed ID: 15276318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Market watch: a framework for biomedical innovation in emerging markets.
    Gautam A; Yang S
    Nat Rev Drug Discov; 2014 Sep; 13(9):646-7. PubMed ID: 25176427
    [No Abstract]   [Full Text] [Related]  

  • 14. Service design. Forecasting the future for the NHS.
    Barrow J; Evennett C
    Health Serv J; 2013 Sep; 123(6368):26-7. PubMed ID: 24383179
    [No Abstract]   [Full Text] [Related]  

  • 15. The Challenge of Keeping Up with a Rapidly Changing Regulatory Landscape.
    Hoxey E
    Biomed Instrum Technol; 2017; 51(3):204-205. PubMed ID: 28530857
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging new technology: are surgeons leading or being led?
    Papa MZ; Zbar AP; Zippel DB
    J Surg Oncol; 2013 Jun; 107(7):683-4. PubMed ID: 23297080
    [No Abstract]   [Full Text] [Related]  

  • 17. Journal of the Royal Society of Medicine. Foreward by the Director of the Centre for Health Technology Evaluation.
    Longson C
    J R Soc Med; 2012 Apr; 105 Suppl 1(Suppl 1):S2. PubMed ID: 22508969
    [No Abstract]   [Full Text] [Related]  

  • 18. [Opportunities and challenges of blockchain technology in the healthcare industry].
    Petre A; Haï N
    Med Sci (Paris); 2018 Oct; 34(10):852-856. PubMed ID: 30451661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How the new European regulation on medical devices will affect innovation.
    Ben-Menahem SM; Nistor-Gallo R; Macia G; von Krogh G; Goldhahn J
    Nat Biomed Eng; 2020 Jun; 4(6):585-590. PubMed ID: 32203280
    [No Abstract]   [Full Text] [Related]  

  • 20. Towards 2020 strategic triad partnerships in ICT and healthcare: bridging the chasms in Canada and the European Union.
    Caro DH
    Healthc Manage Forum; 2002; 15(3):25-31. PubMed ID: 12389534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.